Brief: Synact Pharma Q3 Pretax Loss Widens To SEK 9.1 Million
Nov 13 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q3 PRETAX LOSS SEK 9.1 MILLION VERSUS LOSS SEK 3.6 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr67Hbfm
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026